Abstract: Disclosed are compositions and methods for targeted treatment of cancer, such as HPV-associated cancer. In particular, modified T cell receptor (TCR) T cells are disclosed that can be used with adoptive cell transfer to target and kill cancer cells with reduced antigen escape. Therefore, also disclosed are methods of providing an anti-tumor immunity in a subject with HPV-associated cancer that involves adoptive transfer of the disclosed TCR-T cells.

Abstract: Provided herein are methods for preparing and characterizing CTL cultures and preparations. Also provided herein are methods of determining the presence or absence of trace amounts of viral vectors following the preparation of CTLs.

Abstract: The detergent composition of the invention contains a combination of an anionic surfactant, a defined nonionic surfactant of high hydrophilic/lipophilic balance (HLB) value, optionally a cationic surfactant, optionally a detergency builder, optionally an inorganic non-builder salt, an optionally a polycarboxylate polymer. Further optional detergent ingredients may also be present. The amount of the anionic surfactant is from 5 to 40, preferably from 7 to 30 wt % and the amount of the nonionic surfactant is from 1 to 20, preferably from 1 to 10 wt %, based on the weight of the total composition.

Abstract: The detergent composition of the invention contains a combination of an anionic surfactant, a defined nonionic surfactant of high hydrophilic/lipophilic balance (HLB) value, optionally a cationic surfactant, optionally a detergency builder, optionally an inorganic non-builder salt, an optionally a polycarboxylate polymer. Further optional detergent ingredients may also be present. The amount of the anionic surfactant is from 5 to 40, preferably from 7 to 30 wt % and the amount of the nonionic surfactant is from 1 to 20, preferably from 1 to 10 wt %, based on the weight of the total composition.